News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
BIOTECHNOLOGY VALUE FUND L P
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 12.6% stake in Molecular Partners AG |
| 02/14/2023 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 4.6% stake in IDEAYA Biosciences, Inc. |
| 02/14/2023 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 6.9% stake in Galmed Pharmaceuticals Ltd. |
| 02/14/2023 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 6.4% stake in Merus N.V. |
| 02/14/2023 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 6.5% stake in 89bio, Inc. |
| 02/14/2023 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 8.7% stake in POINT Biopharma Global Inc. |
| 02/14/2023 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 5.1% stake in Crinetics Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 3.2% stake in Arcus Biosciences, Inc. |
| 02/14/2023 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 0% stake in Relmada Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 1.4% stake in Cogent Biosciences, Inc. |
| 02/14/2023 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 16.4% stake in Cullinan Oncology, Inc. |
| 02/14/2023 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 2.1% stake in Syndax Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 10.5% stake in Calliditas Therapeutics AB |
| 02/14/2023 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 10% stake in Calithera Biosciences, Inc. |
| 02/14/2023 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 0% stake in Spero Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 8.1% stake in AN2 Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 5.8% stake in Sutro Biopharma, Inc. |
| 02/14/2023 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 5.6% stake in Viridian Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 5.2% stake in Aileron Therapeutics Inc. |
| 02/14/2023 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 4.9% stake in Aclaris Therapeutics, Inc. |
| 12/23/2022 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 7.4% stake in ERYTECH Pharma S.A. |
| 12/21/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 07/29/2022 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 10.1% stake in CytomX Therapeutics, Inc. |
| 07/19/2022 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 4.5% stake in ContraFect Corporation |
| 07/12/2022 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 19.9% stake in ESSA Pharma Inc. |
| 06/21/2022 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 12.4% stake in 4D Molecular Therapeutics, Inc. |
| 06/06/2022 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 19.4% stake in Repare Therapeutics Inc. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 10% stake in Pieris Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 10% stake in Xenon Pharmaceuticals Inc. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 10% stake in ESSA Pharma Inc. |
| 02/14/2022 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 9.7% stake in AC Immune SA |
|
|
|